118 | 1 | 4 |
下载次数 | 被引频次 | 阅读次数 |
目的 探讨新生儿重症监护病房中先天性遗传代谢性疾病(IMD)的发病特点。方法 回顾性分析2018年10月至2020年10月华中科技大学同济医学院附属武汉儿童医院新生儿重症监护室收治的符合入组标准且接受了血液液相色谱-串联质谱法检测及尿气相色谱-质谱法检测的637例患儿临床资料。结果 637例患儿中,确诊IMD共计36例,总阳性率为5.6%,主要的IMD类型包括有机酸代谢障碍(18/36,50.00%)、氨基酸代谢障碍(7/36,19.44%)、尿素循环障碍(7/36,19.44%)等。有机酸代谢障碍中,主要包括甲基丙二酸血症、丙酸血症、戊二酸血症及异戊酸血症;氨基酸代谢障碍中主要为酪氨酸血症、高苯丙氨酸血症及枫糖尿病等。在IMD诊断明确的36例患儿中,首发表现主要为反应差或昏迷(8/36,22.22%)、纳差(6/36,16.67%)、体重增长缓慢(5/36,13.89%)、皮肤黄染(5/36,13.89%)、腹胀(4/36,11.11%)、抽搐(3/36,8.33%)以及呼吸困难(3/36,8.33%)等。结论 新生儿遗传代谢性疾病临床表现多样,对于存在高危表现的患儿进行筛查有助于早期明确诊断。
Abstract:Objective To explore the pathogenesis characteristics of inherited metabolic disease in the neonatal intense care unit. Methods We retrospectively analyzed the clinical data of 637 neonates between October 2018 and October 2020 who met the inclusion criteria and underwent blood LC-MS-MS and urine GC-MS in the neonatal intensive care unit of Wuhan Children′s Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology. Results A total of 36 newborns were confirmed to have inherited metabolic disease in the 637 neonates,and the total positive rate was 5. 6%,including organic acidemias(18/36,50. 00%),amino acid metabolism(7/36,19. 44%),and urea cycle defect(7/36,19. 44%),et al. Methylmalonicacademia,propionic academia,glutaricacademia and isovaleric acidemia were the most common cause of organic acidemias. Tyrosinemia,hyperphenylalaninemia,and maple syrup urine disease were the main types of amino acid metabolism. The first presentation in these 36 neonates mainly include poor response or coma(8/36,22. 22%),poor appetite(6/36,16. 67%),slow increase of weight(5/36,13. 89%),jaundice(5/36,13. 89%), abdominal distention(4/36,11. 11%),convulse(3/36,8. 33%),and dyspnea(3/36,8. 33%). Conclusion The clinical manifestations of neonatal genetic metabolic diseases are diverse. Screening for children with high-risk manifestations is helpful for early diagnosis.
[1]罗小平,吴薇.重视和加强新生儿遗传代谢病的筛查[J].中华围产医学杂志,2015,18(3):168-171.
[2]李瑛,刘向梅,王欣煜,等.新生儿重症监护病房先天性遗传代谢病筛查及结局随访[J].中国新生儿科杂志,2015,30(1):48-50.
[3] SCOLAMIERO E,COZZOLINO C,ALBANO L,et al. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism[J]. Mol Biosyst,2015,11(6):1525-1535.
[4]黄敬孚.儿科重症医学与遗传代谢病[J].中国小儿急救医学,2014,21(6):337-339.
[5] BOWER A,IMBARD A,BENOIST J F,et al. Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening[J]. Sci Rep,2019,9(1):14098.
[6] VILLORIA J G,PAJARES S,LOPEZ R M,et al. Neonatal screening for inherited metabolic diseases in2016[J]. Semin Pediatr Neurol,2016,23(4):257-272.
[7] CIPRANO L E,RUPAR C A,ZARIC G S. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry:results from a decision-analytic model[J]. Value Health,2007,10(2):83-97.
[8]石惠英,杨长仪,张宝泉,等.新生儿重症监护病房遗传代谢病临床分析[J].中华实用儿科临床杂志,2016,31(20):1556-1558.
[9]邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].北京:人民卫生出版社,2018:957-978.
[10]中华医学会儿科学分会内分泌遗传代谢血组,《中华儿科杂志》编辑委员会.第11届中华医学会儿科学分会内分泌遗传代谢病学术会议纪要[J].中华儿科杂志,2012,50(4):317-320.
[11]徐发林,范甜,段佳佳,等.重症监护病房新生儿有机酸代谢疾病临床分析[J].中国当代儿科杂志,2012,14(5):336-339.
[12]林舒祥,舒剑波,王朝,等. 15851例遗传代谢病高危患儿的临床分析[J].中国当代儿科杂志,2017,19(12):1243-1247.
[13]鄢慧明,贾政军,刘静,等.湖南省565 182例串联质谱新生儿疾病筛查分析[J].中华实用儿科临床杂志,2019,34(20):1541-1545.
[14] ADAWAY J E,KEEVIL B G,OWEN L J. Liquid chromatography tandem mass spectrometry in clinical laboratory[J]. Ann Clin Biochem,2015,52(Pt 1):18-38.
[15] BONHAM J R. The organization of training for laboratory scientists in inherited metabolic disease,newborn screening and pediatric clinical chemistry[J]. Clin Biochem,2014,47(9):763-764.
[16]周婧瑶,张钰,胡琦,等.影响新生儿氨基酸代谢的多因素分析[J].中华实用儿科临床杂志,2020,35(23):1773-1776.
[17]易芳,王玲,王梅,等.胎龄联合出生体重对新生儿遗传代谢病相关代谢物的影响[J].中国当代儿科杂志,2018,20(5):352-357.
[18]吴鹰军,吴时光,李思涛,等.应用串联质谱技术区别早产儿与足月儿血代谢组学生物标志物[J].中华实用儿科临床杂志,2016,31(17):1325-1328.
[19]方芳,张军,江帆.重视小儿胎龄儿病因识别及生长发育管理[J].中华儿科杂志,2019,57(9):660-662.
基本信息:
DOI:10.16389/j.cnki.cn42-1737/n.2022.02.006
中图分类号:R722.1
引用信息:
[1]王劲,王丹,曾凌空等.新生儿重症监护病房先天性遗传代谢性疾病的单中心回顾性分析[J].江汉大学学报(自然科学版),2022,50(02):46-52.DOI:10.16389/j.cnki.cn42-1737/n.2022.02.006.
基金信息: